Patent · US Active

Anti-CD38 binding domains

US11414496B2 · kind B2 · utility

3Cited by

1References

21Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Kathleen Ann Elias · San Francisco, US
Gregory Landes · San Bruno, US
Shweta Singh · Fremont, US
Wouter Korver · South San Francisco, US
Andrew W. Drake · Mountain View, US
Mary Haak-Frendscho · Madison, US
Vinay Bhaskar · South San Francisco, US
Erin Willert · Round Rock, US

Key dates

Filing date	Jan 23, 2020
Grant date	Aug 16, 2022
Priority date	—
Expiry date	Sep 16, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided in this disclosure are anti-CD38 binding domains, a composition comprising the anti-CD38 binding domains, nucleic acids encoding the anti-CD38 binding domains, and a method of using the anti-CD38 binding domains or the composition for treating multiple myeloma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.